Wealth Alliance’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.09M | Sell |
15,844
-338
| -2% | -$23.3K | 0.12% | 156 |
|
2025
Q1 | $1.12M | Buy |
16,182
+4,853
| +43% | +$337K | 0.14% | 148 |
|
2024
Q4 | $975K | Sell |
11,329
-249
| -2% | -$21.4K | 0.12% | 163 |
|
2024
Q3 | $1.38M | Buy |
11,578
+15
| +0.1% | +$1.79K | 0.16% | 121 |
|
2024
Q2 | $1.65M | Buy |
11,563
+245
| +2% | +$35K | 0.21% | 89 |
|
2024
Q1 | $1.45M | Sell |
11,318
-518
| -4% | -$66.5K | 0.19% | 113 |
|
2023
Q4 | $1.22M | Buy |
11,836
+313
| +3% | +$32.4K | 0.17% | 119 |
|
2023
Q3 | $1.05M | Buy |
11,523
+841
| +8% | +$76.5K | 0.17% | 125 |
|
2023
Q2 | $864K | Sell |
10,682
-666
| -6% | -$53.9K | 0.13% | 166 |
|
2023
Q1 | $903K | Sell |
11,348
-1,018
| -8% | -$81K | 0.15% | 152 |
|
2022
Q4 | $837K | Buy |
12,366
+1,232
| +11% | +$83.4K | 0.15% | 157 |
|
2022
Q3 | $555K | Buy |
11,134
+2,370
| +27% | +$118K | 0.11% | 193 |
|
2022
Q2 | $488K | Sell |
8,764
-1,390
| -14% | -$77.4K | 0.09% | 218 |
|
2022
Q1 | $564K | Buy |
10,154
+256
| +3% | +$14.2K | 0.12% | 193 |
|
2021
Q4 | $554K | Sell |
9,898
-38
| -0.4% | -$2.13K | 0.11% | 205 |
|
2021
Q3 | $477K | Sell |
9,936
-250
| -2% | -$12K | 0.11% | 214 |
|
2021
Q2 | $427K | Buy |
10,186
+2
| +0% | +$84 | 0.1% | 233 |
|
2021
Q1 | $343K | Buy |
10,184
+150
| +1% | +$5.05K | 0.1% | 257 |
|
2020
Q4 | $350K | Sell |
10,034
-680
| -6% | -$23.7K | 0.1% | 247 |
|
2020
Q3 | $372K | Buy |
10,714
+144
| +1% | +$5K | 0.13% | 184 |
|
2020
Q2 | $346K | Buy |
10,570
+1,292
| +14% | +$42.3K | 0.14% | 194 |
|
2020
Q1 | $279K | Buy |
+9,278
| New | +$279K | 0.15% | 172 |
|